trandolapril pharmas 0,5 mg tvrde kapsule
pharmas d.o.o., radnička cesta 47, zagreb, hrvatska - trandolapril - kapsula, tvrda - urbroj: 1 kapsula sadrži 0,50 mg trandolaprila
trandolapril pharmas 2 mg tvrde kapsule
pharmas d.o.o., radnička cesta 47, zagreb, hrvatska - trandolapril - kapsula, tvrda - urbroj: 1 kapsula sadrži 2 mg trandolaprila
trandolapril pharmas 4 mg tvrde kapsule
pharmas d.o.o., radnička cesta 47, zagreb, hrvatska - trandolapril - kapsula, tvrda - urbroj: 1 kapsula sadrži 4 mg trandolaprila
trandolapril pharmas 0,5 mg/1 kapsula kapsula, tvrda
pharmas d.o.o. sarajevo - trandolapril - kapsula, tvrda - 0,5 mg/1 kapsula - jedna kapsula, tvrda sadrži: 0,5 mg trandolaprila
trandolapril pharmas 2 mg/1 kapsula kapsula, tvrda
pharmas d.o.o. sarajevo - trandolapril - kapsula, tvrda - 2 mg/1 kapsula - jedna kapsula, tvrda sadrži: 2 mg trandolaprila
ticasa 60 mg/1 tableta filmom obložena tableta
nobel lijek d.o.o. sarajevo - tikagrelor - filmom obložena tableta - 60 mg/1 tableta - 1 filmom obložena tableta sadrži 60 mg tikagrelora
ticasa 90 mg/1 tableta filmom obložena tableta
nobel lijek d.o.o. sarajevo - tikagrelor - filmom obložena tableta - 90 mg/1 tableta - 1 filmom obložena tableta sadrži 90 mg tikagrelora
clopidogrel/acetylsalicylic acid zentiva (previously duocover)
sanofi-aventis groupe - clopidogrel, acetylsalicylic acid - acute coronary syndrome; myocardial infarction - antitrombotska sredstva - akutna koronarna infarkt syndromemyocardial .
lidokain-hlorid galenika 2% 40mg/2ml rastvor za injekciju
"glk pharma" druŠtvo sa ograniČenom odgovornoŠĆu, budva - lidokain - rastvor za injekciju - 40mg/2ml
clopidogrel acino
acino ag - klopidogrel - peripheral vascular diseases; acute coronary syndrome; myocardial infarction; stroke - antitrombotska sredstva - clopidogrel is indicated in adults for the prevention of atherothrombotic events in: , , , patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease, non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa), st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapy, patients suffering from acute coronary syndrome. , ,.